Pharmacokinetics and safety of coformulated bictegravir emtricitabine and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV a phase 23 openlabel singlearm study

C RodriguezE NatukundaRenate StrehlauE VenterS RungmaitreeE et alAfaaf Liberty2025-04-13WOS2352-3018https://hdl.handle.net/10539/44754Pharmacokinetics and safety of coformulated bictegravir emtricitabine and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV a phase 23 openlabel singlearm studyJournal Article